CClinicalTrials.gg
CompletedNCT05205434Updated Mar 9, 2023

Efficacy of Synchronous and Asynchronous Telerehabilitation in COVID-19 Discharges

An interventional study of Synchronous telerehabilitation programme and Asynchronous telerehabilitation programme in COVID-19 and Telerehabilitation, sponsored by Bitlis Eren University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-03-09.

Sponsored by Bitlis Eren University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Sep 2021, registered Jan 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
57
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Investigators aimed to evaluate the effectiveness of exercise programs given by synchronous and asynchronous telerehabilitation methods in patients after discharge from COVID-19.

Read the detailed description

Fifty seven participants will be enrolled. Participants will be randomly divided into 3 groups.

For this purpose, patients will be recruited at the time of discharge from the hospital and two experimental groups with the same physical therapy and educational program will be carried out. participants in the control group will only educational program. Participants in experimental groups will be followed using videoconference interviews from synchronous telerehabilitation methods and mobile application from asynchronous telerehabilitation methods at home. These participants will be given an 8-week exercise program. The exercise program will consist of physical exercises (aerobic and strength exercises) along with breathing exercises and the patients will be evaluated before and after the treatment.

After treatment programs, the functional capacity, performance, and hemodynamic parameters of the participants will be evaluated. Quality of life, physical activity level, anxiety-depression, and fatigue severity will also be evaluated with questionnaires.

02

Conditions studied

  • COVID-19
  • Telerehabilitation

Browse trials for

Keywords

  • COVID-19
  • Telerehabilitation
  • Exercise program
  • Breathing exercises
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 57 is below the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Bitlis Eren University is the lead sponsor of 48 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • COVID-19 patients in the subacute period discharged
  • Be 18 years or older
  • Having received oxygen therapy or mechanical ventilation support in the hospital
  • Access to online interviews and web-based exercises with a secure internet connection
  • Having sufficient speaking and hearing skills for telerehabilitation
  • Volunteer to participate in research

Exclusion criteria

Exclusion Criteria:

  • Unstable clinical condition
  • Having had cerebrovascular disease, intra-articular drug injection or surgery of the lower extremities in the last 6 months
  • Inability to walk independently, even with an assistive device
  • Having serious neuromuscular problems
  • Not being cooperative enough to answer and understand questionnaires and scales
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
57 participants (actual)

Study arms

  • Experimental
    Synchronous telerehabilitation program (Video conference)

    Participants will exercise program at home for an average of 30 minutes a day, 3 days a week, under the supervision of a physiotherapist via synchronized video conference. The program will continue for 8 weeks. The exercise program will consist of physical exercises (aerobic and strength exercises) along with breathing exercises and an educational program. Physical exercises will be adjusted in 3 different difficulty levels: sitting, standing with or without support.

    Other: Synchronous telerehabilitation programme

  • Experimental
    Asynchronous telerehabilitation programme (Mobil app.)

    The same exercises as in the synchronous telerehabilitation program will be done at the same frequency. Participants will watch the videos sent by the investigator via the mobile application and then do the exercises at home. The participants will meet with the investigator once a week to an update exercise program.

    Other: Asynchronous telerehabilitation programme

  • No intervention
    Control

    Participants in this group will only receive an educational program

Interventions

  • OtherSynchronous telerehabilitation programme

    Exercise program and educational program

    Also known as: Video conference

  • OtherAsynchronous telerehabilitation programme

    Exercise program educational program

    Also known as: Mobil application

06

What researchers measure

Primary outcomes

  1. Incremental Shuttle Walk Test (ISWT)

    The participant will be asked to walk around two 9-meter cones and complete them within the given time. Oxygen saturation and heart rate will be measured before and immediately after the test. They will be asked to self-report dyspnea and fatigue according to the modified Borg scale (0-10).

    Time frame: Change from baseline walking distance (meters) of the patients at the end of the 8th week and, postintervation sixth months

Secondary outcomes

  1. 30-Second Chair Stand Test (30 CST)

    The patient will be asked to sit and stand as much as possible within 30 seconds, with his hands crossed over his chest. The number of sitting and staying for 30 seconds will be noted.

    Time frame: Change from baseline number of sitting and staying of the patients at the end of the 8th week and, postintervation sixth months

  2. Brief Physical Performance Battery (BPPB)

    It is a test used to evaluate the lower extremity function of patients. This battery represents the sum of 3 functional tests such as standing stance tests, 4 meters walking test and 5 times chair sit and stand (5STS). Each test is scored between 0 (not completing the test) and 4 (highest performance level)

    Time frame: Change from baseline score of the patients at the end of the 8th week and, postintervation sixth months

Other outcomes

  1. Oxygen Saturation and Heart Rate

    Participants' resting oxygen saturation and heart rate, and oxygen saturation and heart rate after the tests will be evaluated

    Time frame: Change from baseline oxygen saturation (SaO2) and heart rate (beats per minute) of the patients at the end of the 8th week and, postintervation sixth months

  2. Dyspnea and Fatigue Level

    Participants' dyspnea and fatigue level, and dyspnea and fatigue level after the tests will be evaluated according to the Modified Borg (0-10) scale

    Time frame: Change from baseline dyspnea and fatigue of the patients at the end of the 8th week and, postintervation sixth months

  3. Timed Up-Go Test (TUG)

    Participants are asked to get up from the chair, walk 3 m at a comfortable and safe pace, return and sit back in the chair.

    Time frame: Change from baseline time (second) of the patients at the end of the 8th week and, postintervation sixth months

  4. International Physical Activity Questionnaire Short Form (IPAQ)

    It is a scale used to determine the level of physical activity in adults. The scale questions vigorous and moderate physical activity, walking time of at least 10 minutes and daily sitting time in the last 7 days.

    Time frame: Change from baseline metabolic equivalent (MET)-minute/week of the patients at the end of the 8th week and, postintervation sixth months

  5. Hospital Anxiety Depression (HAD) Scale

    The questionnaire, which was filled in by the patient and includes the anxiety and depression subscales, consists of 14 items. Responses are scored between 0-3.

    Time frame: Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months

  6. Fatigue Severity Scale

    This scale is a 9-item scale that measures the severity of fatigue in patients and its effect on one's activities and lifestyle. Responses are scored on a seven-point scale with 1 = strongly disagree and 7 = strongly agree.

    Time frame: Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months

  7. Quality of Life Scale: Short Form-36 (SF-36)

    The self-assessment scale consists of 36 items and 8 sub-dimensions. The scale is evaluated considering the last four weeks. On the scale, 0 points indicate poor health and 100 points indicate good health.

    Time frame: Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months

07

Study locations

1 site
  • Marmara University
    Maltepe, İstanbul 34000, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05205434
Lead sponsor
Bitlis Eren University
Collaborators
Marmara University
Responsible party
Abdurrahman Tanhan (Research Assistant, Bitlis Eren University) — Principal investigator
First posted
Jan 25, 2022
Start date
Sep 25, 2021
Primary completion
Aug 5, 2022
Completion
Sep 7, 2022
Last update
Mar 9, 2023

Study contacts

Abdurrahman TANHAN, MSc
principal investigator · Bitlis Eren University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion